Related Experiment Video
Updated: Jun 28, 2026
07:28
Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
40.7K
Spray-Dried Nanolipid Powders for Pulmonary Drug Delivery: A Comprehensive Mini Review
Mahmoud H Abu Elella1, Arwa Omar Al Khatib1,2, Hisham Al-Obaidi1
1School of Pharmacy, University of Reading, Reading RG6 6UR, UK.
Pharmaceutics
|May 25, 2024
Summary
Pulmonary drug delivery using inhalable nanocarrier powders offers an effective, non-invasive treatment for lung diseases. Solid-lipid and nanostructured-lipid nanocarriers produced via spray drying show promise for respiratory conditions.
Area of Science:
- Pharmaceutical Sciences
- Biomedical Engineering
- Respiratory Medicine
Background:
- Lung diseases are a leading cause of mortality globally, necessitating advanced treatment strategies.
- Pulmonary drug delivery offers a non-invasive, localized route with advantages over traditional methods, avoiding systemic side effects.
- Nanocarrier powders, particularly lipid-based nanoparticles, are promising for respiratory diseases due to deep lung deposition and controlled release.
Purpose of the Study:
- To review ideal criteria for inhalable spray-dried solid-lipid nanocarriers (SLN) and nanostructured-lipid nanocarriers (NLC) for pulmonary administration.
- To discuss promising dry powder inhalation devices for nanolipid powder delivery.
- To explore pulmonary applications of SLN and NLC powders for chronic lung conditions.
Main Methods:
- Literature review focusing on spray-dried nanolipid powders for inhalation.
- Analysis of criteria for inhalable SLN and NLC powders.
- Evaluation of dry powder inhalers (DPIs) and nanolipid applications in lung disease treatment.
Main Results:
- Spray drying is a viable technique for producing inhalable nanolipid powders.
- Specific criteria for SLN and NLC powders optimize deep lung deposition and therapeutic efficacy.
- Dry powder inhalers are suitable devices for delivering these nanomedicines.
Conclusions:
- Inhalable nanolipid powders produced by spray drying represent a significant advancement in pulmonary drug delivery.
- These formulations offer enhanced treatment for chronic lung diseases with improved patient compliance.
- Further research into SLN and NLC delivery systems can optimize respiratory medicine.
Related Concept Videos
01:23Inhaled Medications
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
01:22Drug Delivery: Miscellaneous Routes
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...